300086 康芝藥業
按盤價 
8.740 +1.300 (+17.473%)
8.740 +1.300 (+17.473%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -8.824 | -17.403 | 0.867 | -13.303 | 0.731 |
| 總資產報酬率 ROA (%) | -5.013 | -10.441 | 0.518 | -7.903 | 0.433 |
| 投入資產回報率 ROIC (%) | -5.826 | -11.950 | 0.588 | -8.946 | 0.498 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.364 | 55.356 | 60.007 | 50.796 | 50.457 |
| 營業利潤率 (%) | -34.287 | -47.026 | 3.378 | -39.834 | 2.557 |
| 息稅前利潤/營業總收入 (%) | -30.067 | -44.721 | 6.218 | -36.693 | 4.600 |
| 淨利潤/營業總收入 (%) | -30.064 | -47.466 | 0.699 | -36.949 | 1.264 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 114.831 | 73.428 | 146.641 | 69.002 | -30.263 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.625 | -49.478 | 8.689 | 290.212 |
| 營業外收支淨額/利潤總額(%) | -0.061 | 4.149 | -6.558 | 3.661 | -5.075 | 償債能力分析 |
| 流動比率 (X) | 0.673 | 0.894 | 1.601 | 1.329 | 1.485 |
| 速動比率 (X) | 0.311 | 0.516 | 0.980 | 0.991 | 1.077 |
| 資產負債率 (%) | 42.857 | 41.022 | 36.368 | 40.768 | 36.813 |
| 帶息債務/全部投入資本 (%) | 27.005 | 27.940 | 24.550 | 30.931 | 26.955 |
| 股東權益/帶息債務 (%) | 244.591 | 236.186 | 289.663 | 209.659 | 257.840 |
| 股東權益/負債合計 (%) | 130.369 | 140.639 | 170.741 | 141.076 | 166.157 |
| 利息保障倍數 (X) | -7.161 | -10.303 | 2.040 | -7.883 | 2.123 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.708 | 77.784 | 50.382 | 74.092 | 63.488 |
| 存貨周轉天數 (天) | 314.162 | 361.355 | 247.588 | 251.465 | 177.116 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
